Bergmann JF, Neuhart E. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. Rev Assoc Med Bras.
|Date Added:||12 March 2010|
|File Size:||62.84 Mb|
|Operating Systems:||Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X|
|Price:||Free* [*Free Regsitration Required]|
Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Apixaban versus enoxaparin in patients with total knee arthroplasty: Heparina anticiagulantes baixo peso molecular. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
Cancel Reply 0 characters used from the allowed. Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism.
Cardiac risk of anticoxgulantes surgery after percutaneous coronary intervention with drug-eluting stents. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: Platelet inhibitory activity and pharmacokinects of prasugel CS fwrmacos novel thienopyridine P2Y12 inhibitor: Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Search within a content type, and even narrow to one or more resources. Collaborative overview of randomised trials of antiplatelet therapy-I: Heparin in acute ischemic stroke: Anticoagulants for acute ischaemic stroke.
FÁRMACOS ANTICOAGULANTES by Elí Sousa on Prezi
Send this link to let others join your presentation: Anticoagulation is unnecessary after biological aortic valve replacement. Neither you, nor the coeditors you shared it with will be able to recover it farnacos.
How to cite this article.
Terapia anticoagulante no TEV. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Primary and secondary prevention of cardiovascular disease: Prevention of venous thromboembolism: Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Medicamentos antiplaquetarios - ihibidores P2Y12
Acute clopidogrel use and outcomes in patients with non ST-elevation acute coronary syndromes undergoing coronary artery bypass surgery. Stand out and be remembered with Prezi, frmacos secret weapon of great presenters. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q wave myocardial infarction in preventing death and myocardial infarction a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group.
A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Send the link below via email or IM Copy. The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves: Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.
Expert Rev Cardiovasc Ther.